Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study

Hematology, transfusion and cell therapy(2023)

引用 0|浏览10
暂无评分
摘要
Our data suggest that the ASCT is feasible in selected elderly patients with MM over 65 years of age, achieving response and survival rates similar to those of younger patients.
更多
查看译文
关键词
Multiple myeloma,Elderly,Autologous stem cell transplantation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要